載入...
Structure basis of neutralization by a novel site II/IV antibody against respiratory syncytial virus fusion protein
Globally, human respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections in newborns, young children, and the elderly for which there is no vaccine. The RSV fusion (F) glycoprotein is a major target for vaccine development. Here, we describe a novel monoclonal antib...
Na minha lista:
| 發表在: | PLoS One |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Public Library of Science
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6366758/ https://ncbi.nlm.nih.gov/pubmed/30730999 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0210749 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|